Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03875690Phase 3Active, not recruiting
A Phase 3 trial of methylprednisolone injection in Gastrointestinal cancers, sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Jul 2019; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03875690.